It was determined that neither the MVD nor the Ki67 index were significantly different between treatment and control groups (ANOVA, p = 0.368 and 0.139, respectively), suggesting that the remaining tumor is viable on Day 14. The gene discussed is MKI67; the disease is neoplasm.